Quaker Houghton · NYSE:KWR
Quaker Houghton — Q2 2025 Earnings Presentation
15 slides from Quaker Houghton's earnings presentation, Aug 1, 2025
Slide 1: Second Quarter 2025 Results Investor Conference Call
Quaker Houghton Second Quarter 2025 Results Investor Conference Call
Slide 2: Forward-Looking Statements
Forward-Looking Statements Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operati
Slide 3: Non-GAAP Measures
Non-GAAP Measures The information included in this presentation includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP gross profit, non-GAAP gross margin, taxes on income befor
Slide 4: Speakers
Speakers Joe Berquist Chief Executive Officer, President Tom Coler Executive Vice President, Chief Financial Officer Robert T. Traub Senior Vice President, General Counsel & Corporate Secretary Jeffrey Schnell Vice President, Investor Relations 4 ©2025 Quaker Houghton. All Rights Reserved
Slide 5: Highlights
Highlights Q2’25 YTD 2025 $75m $145m $483m Adjusted EBITDA1 $926m Adjusted EBITDA1 Net Sales Net Sales $42m $39m $1.71 Operating Cash Flow $3.29 Operating Cash Flow Non-GAAP Non-GAAP Earnings per Diluted Share1 $33m Earnings per Diluted Share1 2.6x Leverage Share Ratio1,2 Repurchases 1 This is a non
Slide 6: Financial Snapshot
Financial Snapshot (Unaudited; Dollars in millions, unless otherwise noted) Q2 2025 Q2 2024 Variance(1) YTD 2025 YTD 2024 Variance(1) GAAP Net sales $ 483.4 $ 463.6 $ 19.8 4.3% $ 926.3 $ 933.3 $ (7.0) (0.8%) Gross profit 171.7 175.7 (4.0) (2.3%) 333.0 357.3 (24.3) (6.8%) Gross margin (%) 35.5% 37.9%
Slide 7: Total Company Volume Trend
1 Total Company Volume Trend (kilograms, in thousands) Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Sales volumes in Q2’25 increased 2% Y/Y driven by continued growth in the Asia/Pacific segment and new business wins Sales volumes in
Slide 8: Adjusted EBITDA
1 Adjusted EBITDA (dollars in millions) $320 $84 $311 $288 $75 $274 $257 2 2021 2022 2023 2024 Q2'25 LTM Q2 2024 Q2 2025 Generated $75.5m of adjusted EBITDA in Q2’25 and adjusted EBITDA margins of 15.6% 1 This is a non-GAAP measure, refer to the reconciliations of our non-GAAP measures to their most
Slide 9: Leverage and Liquidity Update
Leverage and Liquidity Update Net Debt and Leverage Ratio1 (Dollars in Millions) • Total debt of $937 million $815 $787 $774 $750 $759 $759 $736 $765 $753 $735 • Cash and cash equivalents of $202 million $696 $628 • Net debt of $735 million $561 $574 $549 $529 $519 $551 • Leverage of 2.6x as of June
Slide 10: Appendix
Appendix Actual and Non-GAAP Results
Slide 11: Non-GAAP Gross Profit and Operating Income Reconciliation
Non-GAAP Gross Profit and Operating Income Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) Three Months Ended Six Months Ended June 30, June 30, Non-GAAP Gross Profit and Margin Reconciliations 2025 2024 2025 2024 Gross profit $ 171,723 $ 175,718 $ 332,983 $ 357,281 Acquisit
Slide 12: Adjusted EBITDA Reconciliation
Adjusted EBITDA Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) Three Months Ended Six Months Ended June 30, June 30, EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin Reconciliations: 2025 2024 2025 2024 Net (loss) income attributable to Quaker Chemical Corporation $ (66,580)
Slide 13: Adjusted EBITDA Reconciliation
Adjusted EBITDA Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) Twelve Months Ended December 31, EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin Reconciliations: 2024 2023 2022 2021 Net income (loss) attributable to Quaker Chemical Corporation $ 116,644 $ 112,748 $ (15,9
Slide 14: Non-GAAP EPS Reconciliation
Non-GAAP EPS Reconciliation Three Months Ended Six Months Ended June 30, June 30, Non-GAAP Earnings per Diluted Share Reconciliations 2025 2024 2025 2024 GAAP (loss) earnings per diluted share attributable to Quaker Chemical Corporation common shareholders $ (3.78) $ 1.94 $ (3.04) $ 3.89 Equity inco
Slide 15: Segment Performance
Segment Performance (Unaudited; Dollars in thousands, except per share amounts) Three Months Ended Six Months Ended June 30, June 30, 2025 2024 2025 2024 Net sales Americas $ 221,062 $ 223,517 $ 434,773 $ 453,271 EMEA 139,923 138,001 269,201 276,423 Asia/Pacific 122,415 102,049 222,340 203,632 Total